During the past decade, Hospital Clinico San Borja Arriaran conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 11 clinical trials were completed, i.e. on average, 110% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clinico San Borja Arriaran" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "ETOP IBCSG Partners Foundation" with 2 trials sponsored, "Kirby Institute" with 2 trials sponsored, "Mannkind Corporation" with 2 trials sponsored and "MedImmune LLC" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clinico San Borja Arriaran" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clinico San Borja Arriaran" are "Breast Cancer" (3 trials), "Stroke" (3 trials), "Aortic Valve Disease" (2 trials), "Atrial Fibrillation" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Hospital Clinico San Borja Arriaran" in a lesser frequency.

Most popular intervention types in "Hospital Clinico San Borja Arriaran" are "Drug" (14 trials), "Device" (3 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "2N(t)RTI" (1 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "AMPLATZER™ LAA Occluder" (1 trials) and "Active comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clinico San Borja Arriaran" are 17 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Clinico San Borja Arriaran". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Hospital Clinico San Borja Arriaran, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clinico San Borja Arriaran, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".